Document is current
Any future updates will be listed below
-
Authors
Holmøy, Trygve http://orcid.org/0000-0002-2529-5664
Fevang, Børre
Olsen, David Benee
Spigset, Olav
Bø, Lars
- License Information
-
More Information
Article History
Received: 8 July 2019
Accepted: 20 July 2019
First Online: 12 August 2019
Ethics approval and consent to participate
: According to Norwegian regulations informed consent and approval from ethics committee are not needed for this report.
: No information that could allow identification of patients are included. Consent to publish from patients are therefore not necessary.
: T Holmøy has received unrestricted research grants to his institution and/or scientific advisory board or speakers honoraria from Biogen, Sanofi, Merck, Novartis, Roche, Santen and Teva; and has participated in clinical trials organized by Biogen, Merck and Roche. L Bø has received unrestricted research grants to his institution and/or scientific advisory board or speakers honoraria from Biogen, Genzyme, Merck, Novartis, Roche and Teva; and has participated in clinical trials organized by Biogen, Merck, Novartis and Roche, and has served as expert witness in litigation for Mylan. B Fevang has received spakers honoraria from MSD and Shire. D Benee Olsen and O Spigset has nothing to disclose.
